Target intelligence / Profile preview

Central catecholamine activity

Molecular classification
Other
01

Overview

Central catecholamine activity encompasses the physiological and biochemical processes involving the neurotransmitters dopamine, norepinephrine, and epinephrine within the brain and spinal cord (StatPearls: Physiology, Catecholamines [1]). These catecholamines are derived from the amino acid tyrosine and are essential for regulating a wide array of functions, including executive function, emotional processing, and the sleep-wake cycle (NCBI: The Catecholamines [2]). Rather than being a single molecular target, central catecholamine activity represents a complex system of enzymes, transporters, and receptors (Britannica: Catecholamine [3]). Dysregulation of this system is a hallmark of several neuropsychiatric and neurodegenerative conditions, such as ADHD and Parkinson's disease (Journal of Clinical Investigation: Catecholamines in health and disease [4]). Therapeutic strategies often aim to restore balance to this activity through the use of stimulants, precursors, or enzyme inhibitors. Consequently, while the term describes a physiological state, it serves as a critical focal point for pharmacological intervention in neurology and psychiatry.

Other names
Central catecholaminergic systemCNS catecholamine signalingCentral adrenergic and dopaminergic activity
02

Mechanism of action

Modulation of the synthesis, storage, release, reuptake, and degradation of dopamine, norepinephrine, and epinephrine in the brain.

03

Biological functions

NeurotransmissionArousalMotor controlMood regulationStress responseCognitive function
04

Disease associations

Parkinson's diseaseAttention deficit hyperactivity disorder (ADHD)DepressionSchizophreniaHypertension
05

Safety considerations

TachycardiaHypertensionPsychosisDependency and abuse potentialInsomnia
06

Interacting drugs

Amphetamine

5 more in the full profile.

07

Biomarkers

Homovanillic acid (HVA)3-methoxy-4-hydroxyphenylglycol (MHPG)Vanillylmandelic acid (VMA)

Beyond the preview

Go deeper on Central catecholamine activity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Central catecholamine activity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call